CAREvs its industry peers
A metric-by-metric comparison of CARE against SIC 6021 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAREThis | — | — | — | — | — | — | — | — | — | — | — | — |
| PBAM | $489M#1 | — | 1.7x#7 | — | — | — | — | 0.0%#7 | — | — | — | — |
| FNLC | $410M#2 | 10.8x#2 | 1.4x#4 | — | — | 27.2%#3 | — | 11.7%#2 | 17.5%#5 | — | — | 4.0%#2 |
| FDBC | $367M#3 | 12.0x#5 | 1.5x#5 | — | — | 35.6%#2 | — | 11.1%#4 | 33.5%#2 | — | — | 2.6%#4 |
| NEWT | $311M#4 | 4.9x#1 | 0.8x#1 | — | — | 19.0%#5 | — | 14.6%#1 | 11.6%#6 | — | — | 9.0%#1 |
| ATLO | $298M#5 | 22.6x#6 | 1.4x#3 | — | — | 86.2%#1 | — | 8.9%#6 | 34.4%#1 | — | — | 2.4%#5 |
| FUNC | $295M#6 | 11.9x#4 | 1.4x#2 | 16.0x#1 | 4.0%#1 | 19.2%#4 | 308.4%#1 | 11.5%#3 | 18.8%#4 | — | — | 2.0%#6 |
| VABK | $284M#7 | 11.5x#3 | 1.5x#6 | — | — | 13.5%#6 | — | 9.9%#5 | 19.0%#3 | — | — | 2.7%#3 |
Peer set: US filers sharing this company's SEC industry classification (SIC 6021). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice